Feature | ACC | February 22, 2021

ACC Abandons In-person Meeting and Goes Entirely Virtual for 2021 Due to COVID

ACC Abandons In-person Meeting and Goes Entirely Virtual for 2021 Due to COVID

February 22, 2021 — The American College of Cardiology (ACC) moved its meeting from March to May 2021 in hopes that COVID concerns would subside by then and vaccinations would play a key role in reducing the risk of COVID-19 transmission. However, the ACC announced today it is clear this is not happening, so it is going to an entirely virtual format for a second year. 

"The college was hopeful that delaying the meeting until the spring would allow an opportunity for ACC and its membership to safely reconnect in Atlanta, Ga., for the 70th Annual Scientific Session and Expo. Unfortunately, with the continued presence of COVID-19 and a sudden, sharp increase in ongoing travel restrictions imposed by healthcare institutions, academic medical centers and exhibitor companies, the decision has had to be made to transition the meeting from a hybrid model to entirely virtual," said a statement from Pamela B. Morris, M.D., FACC, ACC.21 chair, and Douglas E. Drachman, M.D., FACC, the ACC.21 vice chair. 

The event, set for May 15-17, 2021, was supposed to be in-person with a virtual component for this who could not, or did not want to attend in person. However, there has been apprehension from vendors to attend medical conferences again until the doctors and other hospital staff are allowed to attend. Many hospitals and healthcare systems continue to have travel bans in place for their staff as part of their pandemic containment strategy. Part of the reason for travel bans also ensures all staff are available locally in case of implementing emergency plans if COVID cases suddenly rise. 

ACC said it is now focusing efforts on creating an all virtual experience. Morris said ACC.21 will be a world-class program delivered through an innovative digital platform built for learning, collaboration and networking. ACC.21 will also offer a robust virtual expo with both exhibits and education from Learning Destinations.

In 2020, ACC decided to cancel the in-person meeting less than a month from the conference. It quickly had to reorganize a scaled back virtual meeting in just three weeks. 

COVID Vaccines Still Unavailable for Vendors and Convention Staff

While there are high hopes that the vaccines will allow clinicians to attend in-person meetings, non-clinical vendor attendees and the large support staffs needed to organize and run inperson conferences may not qualify to receive the vaccine for months. Some estimates place vaccine availability for non-essential workers and healthy individuals under age 65 may not be possibly until this summer or fall.

Most cardiology societies decided early on not to chance an in-person meeting, including EHRA, SCAI, EuroCMR, ASE, SCCT and ESC, which are all planning virtual meetings in 2021. HRS is planning a hybrid meeting, with virtual courses June 30 and an in-person meeting July 28-31 in Boston. Other organizations are still waiting to see what happens with the virus during the first part of the year before deciding on whether to host in-person meetings in the fall of 2021. 

For more information on ACC.21: https://accscientificsession.acc.org/?utm_campaign=acc21&utm_medium=email_newsletter&utm_source=acc21update&utm_content=A21125

Related Content

To help monitor the health of ACC 2021 in-person attendees for signs of COVID infection, the meeting will use BioIntelliSense's wearable BioButton continuous wireless temperature and vital signs monitoring. The wearable monitor is the size of a coin and is disposable.

To help monitor the health of ACC 2021 in-person attendees for signs of COVID infection, the meeting will use BioIntelliSense's wearable BioButton continuous wireless temperature and vital signs monitoring. The wearable monitor is the size of a coin and is disposable.

News | ACC | February 09, 2021 | By Dave Fornell, Editor
February 9, 2021 — Despite the ongoing COVID-19 pandemic, the American College of Cardiology (ACC) is hoping its annu
The American College of Cardiology (ACC) released a list of the latest practice-changing presentations at the ACC.20 annual meeting March 28-30, 2020, in Chicago. This includes five late-breaking clinical trial (LBCT) sessions and three featured clinical research sessions. There also are two LBCT deep-dive sessions where the experts will break down the hottest trials and attendees can find out what the impact might be on the practice of cardiology and patients.
Feature | ACC | April 09, 2020 | Dave Fornell, Editor
Here is the list of American College of Cardiology (ACC) practice-
ACC Cancels 2020 Conference Amid Coronavirus Concerns. #COVID19 #coronavirus #2019nCoV
Feature | ACC | March 09, 2020 | Dave Fornell, Editor
March 9, 2020 — Less than week after the American College of Cardiolog...
American College of Cardiology Names Douglas Drachman Next Annual Scientific Session Vice Chair

Image courtesy of Massachusetts General Hospital

News | ACC | October 08, 2019
Douglas Drachman, M.D., FACC, has been selected as the next vice chair of the American College of Cardiology’s (ACC)...
SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions. FFR in the cath lab.

SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions.

Feature | ACC | March 27, 2019 | Greg Freiherr, Contributing Editor
The fingerprints of value-added medicine were all over products and works-in-progress on the exhibit floor of the a

The opening late-breaking trial at ACC 2019 is the Apple Heart Study, a large-scale, app-based study to identify atrial fibrillation using a smartwatch. Earlier, smaller trials showed this approach might be used in a population health application to proactively identify AFib patients earlier.

Feature | ACC | March 19, 2019
The American College of Cardiology (ACC) released a list of the late
A patient who received HeartMate III LVAD system at ACC.18. The HeartMate 3 was the topic of of the the key late-breaking trials at #ACC18

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC.18. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at this year's conference.

Feature | ACC | March 27, 2018 | Dave Fornell
There were several notable presentations of new data on cardiovascular technologies at the recent 2018 American Colle
Drug Stops Dangerous Bleeding in Patients Taking Factor Xa Inhibitors

Connolly 

News | ACC | March 22, 2018
March 22, 2018 — The experimental drug...
Videos | ACC | March 21, 2018
DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at
ACC 2018 Late-Breaking Trials Announced
News | ACC | March 21, 2018
Here is a list of the American College of Cardiology (ACC) 2018 annual meeting late-breaking clinical trials presente